Literature DB >> 7057316

Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol.

M A Guggenheim, S P Ringel, A Silverman, B E Grabert.   

Abstract

We have studied four children (ages 6 to 17 years) with chronic cholestasis who developed a slowly progressive neuromuscular disease characterized by ataxia, dysmetria, areflexia, loss of vibratory sensation, and a variable ophthalmoplegia. Serum vitamin E concentration were low in all patients prior to treatment. Muscle histochemical studies in all four patients showed autofluorescent basophilic esterase and acid phosphatase-positive cytoplasmic inclusions and occasional necrotic fibers. These distinctive muscle changes are similar to those described in vitamin E-deficient animals. Intramuscular injections of alpha tocopherol were required in three patients to achieve normal serum vitamin E values. High-dose oral supplementation was effective in one patient. After normalization of serum vitamin E concentrations for six to 14 months, the neurologic disease has improved in all four patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057316     DOI: 10.1016/s0022-3476(82)80234-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Isolated lipase and colipase deficiency in two brothers.

Authors:  M Ligumsky; E Granot; D Branski; H Stankiewicz; R Goldstein
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Serum vitamin E concentrations are normal in Friedreich's ataxia.

Authors:  D P Muller; S Matthews; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

3.  Lumbar and cortical somatosensory evoked potentials in rats with vitamin E deficiency.

Authors:  M A Goss-Sampson; A Kriss; J R Muddle; P K Thomas; D P Muller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

4.  Physiological and therapeutic role of vitamin E in humans: an update.

Authors:  K D Moudgil; B S Narang
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

Review 5.  25 Hydroxyvitamin D and vitamin E absorption in healthy children and children with chronic intrahepatic cholestasis.

Authors:  S Issa; H W Rotthauwe; W Burmeister
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

Review 6.  Vitamin therapy in the absence of obvious deficiency. What is the evidence?

Authors:  L Ovesen
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

Review 7.  Vitamin E--its role in neurological function.

Authors:  D P Muller
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

8.  Neuropathy secondary to vitamin E deficiency in acquired intestinal malabsorption.

Authors:  L Palmucci; C Doriguzzi; L Orsi; W Troni; S De Angelis; F Belliardo
Journal:  Ital J Neurol Sci       Date:  1988-12

9.  Tocopherol-phospholipid liposomes: maximum content and stability to serum proteins.

Authors:  M Halks-Miller; L S Guo; R L Hamilton
Journal:  Lipids       Date:  1985-03       Impact factor: 1.880

Review 10.  Dosage and formulation issues: oral vitamin E therapy in children.

Authors:  Tone Westergren; Betty Kalikstad
Journal:  Eur J Clin Pharmacol       Date:  2009-10-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.